title: Tumor Necrosis Factor-Associated Protein 1 (TRAP1) is Released from the Mitochondria Following 6-hydroxydopamine Treatment.
abstract: Parkinson's disease (PD) is a common neurodegenerative disorder characterized by progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta. Most cases are sporadic and its etiology is incompletely understood. However, increasing evidence suggests that oxidative stress and mitochondrial dysfunction may be involved in the pathogenesis of Parkinson's disease. The aim of this study was to investigate changes in mitochondrial protein profiles during dopaminergic neuronal cell death using two-dimensional gel electrophoresis in conjunction with mass spectrometry. Several protein spots were found to be significantly altered following treatment of MN9D dopaminergic neuronal cells with 6-hydroxydopamine (6-OHDA). Among several identified candidates, TNF receptor-associated protein 1 (TRAP1), a mitochondrial molecular chaperone, was released from the mitochondria into the cytosol in MN9D cells as well as primary cultures of dopaminergic neurons following 6-OHDA treatment. This event was drug-specific in that such apoptotic inducers as staurosporine and etoposide did not cause translocation of TRAP1 into the cytosol. To our knowledge, the present study is the first to demonstrate the drug-induced subcellular translocation of TRAP1 during neurodegeneration. Further studies delineating cellular mechanism associated with this phenomenon and its functional consequence may provide better understanding of dopaminergic neurodegeneration that underlies PD pathogenesis.
authors.affiliation: Department of Systems Biology, Yonsei University College of Life Science and Biotechnology, Seoul, Korea.
authors.forename: Dong-Ik
authors.initials: DI
authors.lastname: Shin
authors.affiliation: Department of Systems Biology, Yonsei University College of Life Science and Biotechnology, Seoul, Korea.
authors.forename: Young J
authors.initials: YJ
authors.lastname: Oh
keywords: 6-hydroxydopamine; Parkinson's disease; TRAP1; mitochondria; proteomics
references.citation: Hum Mol Genet. 2010 Nov 15;19(22):4437-52
references.pmid: 20817635
references.citation: Cell Death Differ. 2005 Mar;12(3):255-65
references.pmid: 15637643
references.citation: J Proteomics. 2009 Nov 2;73(1):10-29
references.pmid: 19632367
references.citation: Electrophoresis. 2006 Apr;27(8):1556-73
references.pmid: 16555340
references.citation: Proteomics. 2004 Dec;4(12):3943-52
references.pmid: 15526345
references.citation: Mol Cell Biol. 1996 Sep;16(9):4691-9
references.pmid: 8756626
references.citation: Biochim Biophys Acta. 2006 Sep;1763(9):977-89
references.pmid: 16949164
references.citation: Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10793-8
references.pmid: 16818890
references.citation: J Neurosci. 2003 Jun 15;23(12):5069-78
references.pmid: 12832530
references.citation: J Biol Chem. 2007 Jul 13;282(28):20553-60
references.pmid: 17513296
references.citation: Cell Death Differ. 2001 Dec;8(12):1136-42
references.pmid: 11753562
references.citation: Biogerontology. 2008 Dec;9(6):391-403
references.pmid: 18770009
references.citation: Biochemistry. 2009 Mar 10;48(9):2045-52
references.pmid: 19152501
references.citation: PLoS Biol. 2007 Jul;5(7):e172
references.pmid: 17579517
references.citation: J Biol Chem. 2002 Mar 1;277(9):7086-91
references.pmid: 11751892
references.citation: Neurosci Lett. 2003 Nov 27;352(1):17-20
references.pmid: 14615039
references.citation: EMBO J. 2003 Sep 1;22(17):4385-99
references.pmid: 12941691
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1638-43
references.pmid: 18230723
references.citation: Ann Neurol. 2006 Nov;60(5):557-69
references.pmid: 17120249
references.citation: Brain Res Mol Brain Res. 2005 Mar 24;134(1):119-38
references.pmid: 15790536
references.citation: Proteomics. 2008 Mar;8(6):1266-75
references.pmid: 18338827
references.citation: J Cereb Blood Flow Metab. 2009 Feb;29(2):365-74
references.pmid: 18985056
references.citation: J Neurol Sci. 1991 Aug;104(2):203-8
references.pmid: 1658241
references.citation: Lancet. 1989 Jun 3;1(8649):1269
references.pmid: 2566813
references.citation: Biochem Biophys Res Commun. 2008 Dec 19;377(3):975-80
references.pmid: 18957282
references.citation: Mol Cell. 2009 Mar 13;33(5):627-38
references.pmid: 19285945
references.citation: J Biol Chem. 1995 Feb 24;270(8):3574-81
references.pmid: 7876093
references.citation: Biochem Biophys Res Commun. 1989 Sep 29;163(3):1450-5
references.pmid: 2551290
references.citation: J Neural Transm (Vienna). 2008 Oct;115(10):1413-30
references.pmid: 18523721
references.citation: Clin Chim Acta. 2005 Jul 24;357(2):202-9
references.pmid: 15946658
references.citation: Neurochem Res. 2008 Dec;33(12):2565-74
references.pmid: 18473170
references.citation: EMBO Mol Med. 2009 Jun;1(3):152-65
references.pmid: 20049715
references.citation: PLoS Biol. 2007 Jul;5(7):e206
references.pmid: 17638420
references.citation: Exp Cell Res. 2000 Oct 10;260(1):30-9
references.pmid: 11010808
references.citation: Nat Neurosci. 2004 May;7(5):440-5
references.pmid: 15114355
references.citation: Adv Neurol. 1993;60:288-91
references.pmid: 8420145
references.citation: J Neurochem. 2007 Aug;102(4):1395-409
references.pmid: 17532790
references.citation: J Cell Biochem. 2007 Feb 1;100(2):474-86
references.pmid: 16927372
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2005 Aug 5;137B(1):5-16
references.pmid: 15965975
references.citation: Ann Neurol. 1992 Dec;32(6):782-8
references.pmid: 1471869
references.citation: Cell Death Differ. 2005 May;12(5):453-62
references.pmid: 15933725
references.citation: Exp Gerontol. 2007 Apr;42(4):263-74
references.pmid: 17188442
references.citation: Biochem Biophys Res Commun. 2011 Jun 24;410(1):114-20
references.pmid: 21640711
references.citation: Mol Cell Proteomics. 2006 Jul;5(7):1193-204
references.pmid: 16565515
references.citation: Am J Clin Pathol. 2008 Apr;129(4):526-9
references.pmid: 18343778
references.citation: Curr Opin Genet Dev. 2003 Jun;13(3):253-61
references.pmid: 12787787
references.citation: Science. 2004 May 21;304(5674):1158-60
references.pmid: 15087508
references.citation: Int J Hyperthermia. 2005 Aug;21(5):403-19
references.pmid: 16048838
references.citation: Stress. 2007 Nov;10(4):342-50
references.pmid: 17853063
references.citation: Gynecol Oncol. 2010 May;117(2):177-82
references.pmid: 19942270
references.citation: J Biol Chem. 2008 Apr 11;283(15):9986-98
references.pmid: 18250162
references.citation: J Neural Transm (Vienna). 2004 Dec;111(12):1543-73
references.pmid: 15455214
references.citation: Mov Disord. 2011 Aug 1;26(9):1639-47
references.pmid: 21542017
references.citation: Neurosci Lett. 2008 Jul 11;439(2):125-8
references.pmid: 18514418
references.citation: Trends Mol Med. 2010 Jan;16(1):27-36
references.pmid: 20036196
references.citation: J Neurosci Res. 2009 Jan;87(1):123-9
references.pmid: 18711745
references.citation: J Cereb Blood Flow Metab. 2008 May;28(5):1009-16
references.pmid: 18091755
references.citation: Neurobiol Dis. 2008 Mar;29(3):477-89
references.pmid: 18226537
references.citation: Nature. 2007 Aug 16;448(7155):759-60
references.pmid: 17700685
references.citation: Glia. 2006 Apr 15;53(6):567-82
references.pmid: 16419087